Decoy Therapeutics is trading at $2.88, up +6.93%, despite broader weakness in major U.S. indexes.
- No confirmed company announcement has been identified as explaining the September 14, 2026 gain.
- A special shareholder meeting is scheduled for September 14, 2026, covering warrant exercises and authorized-share changes; it was previously disclosed, and its direct market impact is unclear.
- The stock was reported 10.04% higher premarket at $2.96 before easing.